I appreciated the clarity re arrangements with Sydney uni, all positive as far as I can see. Item 10(b) is intriguing. You could read it a few ways. Perhaps Archer confidence in passing significant development milestones before December 2022. Almost funny that some are selling with major IP announcements seemingly imminent, trading games I guess. I think the current hoo-ha will be forgotten quickly if another big patent drops and will seem like a storm in a tea cup if/when archer achieves cubit control. I wonder if they are close to cubit control. The talk of biosensor reminded me that we have a prototype- current step is to miniaturise and put it on a chip - huge potential in its own right.
AXE Price at posting:
$1.66 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)